This report from Life Science Intelligence provides the latest market data for the Global Neurovascular Interventional Devices Market. Information covered by this report includes:
This report includes findings on the impact of the COVID-19 pandemic on the global neurovascular interventional devices. These devices are primarily for the treatment of stroke (hemorrhagic & ischemic). The forecast period covered by this snapshot is from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Cardinal Health, Penumbra, Stryker, Terumo, and others. The report provides insights into trends, drivers, and limiters of the neurovascular devices market.
Cerenovus/Johnson & Johnson